The pneumococcal vaccine is intended to protect against infection caused by the bacteria Streptococcus pneumonia. Pneumococcal vaccinations are divided into two types: pneumococcal conjugate vaccine and pneumococcal polysaccharide vaccine.
Pneumococcal conjugate vaccine is recommended by the Centers for Disease Control and Prevention (CDC) for all children under the age of two, all adults 65 and older, and people aged 2-64 with specific medical problems. All adults 65 and older, people 2-64 years old with certain medical conditions, and adults 19-64 years old who smoke cigarettes should get the pneumococcal polysaccharide vaccine, according to the CDC.
According to Coherent Market Insights, the global pneumococcal vaccines market was predicted to be worth US$ 7,376.6 million in 2018 and is expected to grow at a CAGR of 7.5 percent between 2018 and 2026.
Read more @ https://bit.ly/3zm6vDN
Source:
https://www.coherentmarketinsights.com/market-insight/pneumococcal-vaccines-market-2295
